Company Description
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors.
The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma.
It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer.
The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021.
The company was founded in 2016 and is headquartered in London, the United Kingdom.
| Country | GB |
| IPO Date | Mar 31, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 204 |
| CEO | Dr. Iraj Ali Ph.D. |
Contact Details
Address: 245 Hammersmith Road London, GB | |
| Website | https://www.achillestx.com |
Stock Details
| Ticker Symbol | ACHL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001830749 |
| CUSIP Number | 00449L102 |
| ISIN Number | US00449L1026 |
| Employer ID | 00-0000000 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Iraj Ali Ph.D. | Chief Executive Officer & Director |
| Robert Coutts | Chief Financial Officer |
| Daniel Carey Cazel Hood | General Counsel & Company Secretary |
| Dr. Charles Swanton FMEDSCI, M.D., Ph.D. | Founder & Member of Scientific Advisory Board |
| Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. | Founder & Member of Scientific Advisory Board |
| Dr. Sergio A. Quezada Ph.D. | Founder & Chief Scientific Officer |
| Edward Samuel | Executive Vice President of Technical Operations |
| Julia Wilson | Head of Communications |
| Lee M. Stern | Vice President of Investor Relations & External Communications |
| Tariq Ahmed | Executive Vice President of People |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 02, 2024 | 6-K | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | 6-K | Filing |
| Sep 25, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 19, 2024 | 6-K | Filing |
| Aug 14, 2024 | 6-K | Filing |
| Aug 05, 2024 | 6-K | Filing |
| Jun 27, 2024 | 6-K | Filing |
| May 24, 2024 | 6-K | Filing |
| May 17, 2024 | 6-K | Filing |